TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI)
CUSIP: 89680M101
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 61,418,480
- Total 13F shares
- 925,707
- Share change
- +246,105
- Total reported value
- $9,026,910
- Price per share
- $9.75
- Number of holders
- 24
- Value change
- +$2,616,406
- Number of buys
- 14
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 89680M101?
CUSIP 89680M101 identifies TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89680M101:
Top shareholders of TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MedTech Acquisition Sponsor LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
6,250,000
mixed-class rows
|
$65,538,115 | — | 26 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.27%
|
165,136
|
$1,395,399 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
125,762
|
$1,063,067 | — | 31 Dec 2023 | |
| Magnetar Financial LLC |
13F
3/4/5
|
Company · 10%+ Owner |
—
class O/S missing
|
879,509
|
$941,075 | — | 31 Dec 2023 | |
| HC Advisors, LLC |
13F
|
Company |
0.17%
|
101,736
|
$859,669 | — | 31 Dec 2023 | |
| James Alecxih |
3/4/5
|
President, Device Technology |
—
class O/S missing
|
94,754
|
$521,147 | — | 10 Aug 2023 | |
| Connecticut Wealth Management, LLC |
13F
|
Company |
0.09%
|
57,188
|
$483,239 | — | 31 Dec 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
—
mixed-class rows
|
77,942
mixed-class rows
|
$440,000 | — | 31 Dec 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
—
mixed-class rows
|
333,334
mixed-class rows
|
$396,674 | — | 31 Dec 2023 | |
| Steven C. Katz |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
173,587
mixed-class rows
|
$377,229 | — | 12 Feb 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
—
class O/S missing
|
285,864
|
$340,178 | — | 31 Dec 2023 | |
| Anson Capital, Inc. |
13F
|
Company |
0.06%
|
35,005
|
$295,792 | — | 31 Dec 2023 | |
| Laird Norton Wetherby Wealth Management, LLC |
13F
|
Company |
0.06%
|
34,950
|
$295,328 | — | 31 Dec 2023 | |
| Tyche Wealth Partners LLC |
13F
|
Company |
0.04%
|
26,664
|
$225,311 | — | 31 Dec 2023 | |
| Exos TFP Holdings LLC |
13F
|
Company |
—
class O/S missing
|
167,610
|
$199,456 | — | 31 Dec 2023 | |
| Vestcor Inc |
13F
|
Company |
—
class O/S missing
|
148,755
|
$177,000 | — | 31 Dec 2023 | |
| MSD Partners, L.P. |
13F
|
Company |
—
class O/S missing
|
133,333
|
$158,666 | — | 31 Dec 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
—
class O/S missing
|
133,333
|
$158,666 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
18,190
|
$153,706 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
16,815
|
$142,087 | — | 31 Dec 2023 | |
| Creative Planning |
13F
|
Company |
0.03%
|
16,216
|
$137,025 | — | 31 Dec 2023 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.03%
|
15,554
|
$131,000 | — | 31 Dec 2023 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
103,750
|
$123,462 | — | 31 Dec 2023 | |
| Bracebridge Capital, LLC |
13F
|
Company |
—
class O/S missing
|
98,857
|
$117,640 | — | 31 Dec 2023 | |
| KIM, LLC |
13F
|
Company |
—
class O/S missing
|
89,007
|
$105,918 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
12,489
|
$105,532 | — | 31 Dec 2023 | |
| Walleye Capital LLC |
13F
|
Company |
—
class O/S missing
|
77,043
|
$91,681 | — | 31 Dec 2023 | |
| Sequoia Financial Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
62,187
|
$74,003 | — | 31 Dec 2023 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
—
class O/S missing
|
61,658
|
$73,373 | — | 31 Dec 2023 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
50,415
|
$59,994 | — | 31 Dec 2023 | |
| ARISTEIA CAPITAL, L.L.C. |
13F
|
Company |
—
class O/S missing
|
53,561
|
$57,310 | — | 31 Dec 2023 | |
| CastleKnight Management LP |
13F
|
Company |
—
class O/S missing
|
46,371
|
$55,181 | — | 31 Dec 2023 | |
| Walleye Trading LLC |
13F
|
Company |
—
class O/S missing
|
43,336
|
$51,570 | — | 31 Dec 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
class O/S missing
|
17,174
|
$20,437 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
mixed-class rows
|
2,015
mixed-class rows
|
$16,721 | — | 31 Dec 2023 | |
| Foster Victor Wealth Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
12,322
|
$13,308 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,317
|
$11,129 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
1,270
|
$10,732 | — | 31 Dec 2023 | |
| Richard Charles Hoertkorn |
13F
|
Individual |
0%
|
668
|
$5,645 | — | 31 Dec 2023 | |
| GPS Wealth Strategies Group, LLC |
13F
|
Company |
0%
|
657
|
$5,552 | — | 31 Dec 2023 |
Institutional Holders of TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI) as of Q1 2024
As of 31 Mar 2024,
TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
925,707 shares.
The largest 10 holders included
Duquesne Family Office LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, Connecticut Wealth Management, LLC, BlackRock Inc., Laird Norton Wetherby Wealth Management, LLC, NORTHERN TRUST CORP, Anson Capital, Inc., and MILLENNIUM MANAGEMENT LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
19
Q1 2024 holders
24
Holder diff
5
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.